Inyx acquires CMSL from UCB

Inyx acquires CMSL from UCB

By Wai Lang Chu

Drug delivery specialists, Inyx has announced the acquisition of
Celltech Manufacturing Services from biopharmaceutical company UCB
for €27.5 million (€22.3 million). The acquisition adds to Inyx's
recently established operating...

Xenogen in Japan

Xenogen in Japan

SC Biosciences is to be the exclusive distributor of sensitive
tools for drug discovery with the announcement this week that it
will distribute in vivo imaging technology in Japan for US company
Xenogen corporation.


Follow us


View more


Featured Suppliers

All suppliers